ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,263Medicare Part D Prescriptions Filled, Including Refills

Rank: 65 out of 680

$1.84M Total Retail Price of All Prescriptions

Rank: 9 out of 680

594 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 594 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

10% of this provider’s 594 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 13,106 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

31% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$101 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 492 394 1 2
METFORMIN HCL 471 374 2 8
FUROSEMIDE 462 375 3 6
OMEPRAZOLE 457 374 4 7
FENOFIBRATE 453 317 5 66
POTASSIUM CHLORIDE 384 300 6 14
GABAPENTIN 382 264 7 15
HYDROCHLOROTHIAZIDE 354 252 8 9
LOVASTATIN 308 212 9 44
BENAZEPRIL HCL 303 221 10 40
AMLODIPINE BESYLATE 299 193 11 1
METOPROLOL TARTRATE 276 188 12 12
WARFARIN SODIUM 239 197 13 20
CITALOPRAM HBR 220 169 14 22
SIMVASTATIN 216 175 15 3
ZOLPIDEM TARTRATE 214 152 16 17
NEXIUM 210 138 17 16
DONEPEZIL HCL 207 199 18 27
HYDROCODONE-ACETAMINOPHEN 201 112 S3 19 4
ISOSORBIDE MONONITRATE ER 182 156 20 59
JANUVIA 179 135 21 60
CYMBALTA 172 101 22 46
GLIMEPIRIDE 160 121 23 29
PANTOPRAZOLE SODIUM 160 107 23 30
CRESTOR 149 128 25 25
ESCITALOPRAM OXALATE 146 78 26 45
METOPROLOL SUCCINATE 143 99 27 13
LOVAZA 142 81 28 119
ALLOPURINOL 139 123 29 33
SPIRONOLACTONE 139 116 29 82
SPIRIVA 137 119 31 70
MELOXICAM 137 112 31 24
BYSTOLIC 134 118 33 79
CARVEDILOL 134 127 33 23
DIOVAN 129 103 35 31
ONGLYZA 127 111 36 136
LEVOFLOXACIN 126 85 37 97
CLOPIDOGREL 123 95 38 26
RAMIPRIL 120 64 39 69
LISINOPRIL 118 89 40 5
DIOVAN HCT 117 91 41 55
CLONIDINE HCL 116 90 42 36
LOSARTAN POTASSIUM 115 102 43 21
TRAMADOL HCL-ACETAMINOPHEN 115 82 43 153
DIGOXIN 108 94 45 58
PLAVIX 107 89 46 39
LEVEMIR FLEXPEN 106 92 47 186
MIRTAZAPINE 105 73 48 78
LACTULOSE 103 77 49 92
ATORVASTATIN CALCIUM 102 71 50 11
QUETIAPINE FUMARATE 101 57 51 64
SULFAMETHOXAZOLE-TRIMETHOPRIM 101 67 51 94
RANITIDINE HCL 97 52 53 56
DEXILANT 93 41 54 171
QUINAPRIL HCL 91 75 55 104
TAMSULOSIN HCL 89 64 56 34
GLIPIZIDE ER 88 65 57 108
NASONEX 86 69 58 197
AMLODIPINE BESYLATE-BENAZEPRIL 84 64 59 43
CELEBREX 83 76 60 90
SERTRALINE HCL 82 53 61 28
PAROXETINE HCL 82 46 61 76
METOCLOPRAMIDE HCL 82 57 61 118
PROMETHAZINE HCL 81 34 R 64 96
FLUOXETINE HCL 80 80 65 74
CIPROFLOXACIN HCL 80 50 65 57
CYCLOBENZAPRINE HCL 80 47 R 65 81
ACTOS 79 72 68 114
SYNTHROID 79 60 68 38
SINGULAIR 78 64 70 91
TRAMADOL HCL 77 73 71 18
ADVAIR DISKUS 74 62 72 53
GLIPIZIDE 73 71 73 63
DICYCLOMINE HCL 69 34 74 278
POLYETHYLENE GLYCOL 3350 68 51 75 62
MONTELUKAST SODIUM 65 51 76 157
LYRICA 65 40 76 77
NAMENDA 65 65 76 35
EXELON 62 55 79 112
GENERLAC 62 47 79 262
AZITHROMYCIN 61 44 81 42
METRONIDAZOLE 60 45 82 306
KLOR-CON M20 58 57 83 61
SUCRALFATE 56 48 84 160
FLUTICASONE PROPIONATE 55 39 85 41
OXYBUTYNIN CHLORIDE ER 55 55 85 143
PREDNISONE 55 43 85 50
MEGESTROL ACETATE 54 50 R 88 88
TRICOR 53 47 89 98
DILTIAZEM 24HR ER 52 38 90 132
ATENOLOL 52 44 90 19
OLANZAPINE 51 27 92 116
RIBAPAK 50 0 93 463
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.